Fed. Circ. Upholds Rejection Of Cancer Patent Claim

Law360, New York (October 31, 2008, 12:00 AM EDT) -- A patent application describing a method for treating a rare form of cancer was appropriately rejected for lacking adequate written description because the patent's specification described only a single antibody, while the contested patent claim involved a much larger grouping of antibodies, the U.S. Court of Appeals for the Federal Circuit has ruled.

A three-judge panel of the appeals court on Thursday rejected the inventor's bid to overturn a ruling by the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences, which had affirmed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.